{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:39:05Z","timestamp":1792589945728,"version":"4.5.0"},"reference-count":19,"publisher":"MyJove Corporation","issue":"231","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/71138","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:00:52Z","timestamp":1779231652000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinically Relevant Transplantable Tumor Models for Studying Metastatic Ovarian Cancer and Therapeutic Response in Mouse"],"prefix":"10.3791","author":[{"given":"Megha J.","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Alfaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayokunnumi","family":"Ogunsanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swethakumar","family":"Basavarajaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achuth","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"1","key":"ref1","first-page":"e70043","type":"journal-article","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(1):e70043. doi: 10.3322\/caac.70043.","journal-title":"CA Cancer J Clin"},{"issue":"38","key":"ref2","first-page":"635","type":"journal-article","article-title":"Ovarian cancer: diagnosis and treatment","volume":"108","author":"Burges","year":"2011","unstructured":"Burges A, Schmalfeldt B. Ovarian cancer: diagnosis and treatment. Dtsch Arztebl Int. 2011;108(38):635-641. doi: 10.3238\/arztebl.2011.0635.","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/diagnostics15040406","type":"journal-article","article-title":"Early diagnosis of ovarian cancer: a comprehensive review of the advances, challenges, and future directions","volume":"15","author":"Hong","year":"2025","unstructured":"Hong MK, Ding DC. Early diagnosis of ovarian cancer: a comprehensive review of the advances, challenges, and future directions. Diagnostics (Basel). 2025;15(4):406. doi: 10.3390\/diagnostics15040406.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.5306\/wjco.v16.i6.108393","type":"journal-article","article-title":"Demographic trends in mortality due to ovarian cancer in the United States, 1999-2020","volume":"16","author":"Razaq","year":"2025","unstructured":"Razaq L, Dhali A, Maity R, Faisal AR, Hafeez AS, Zaman A, et al. Demographic trends in mortality due to ovarian cancer in the United States, 1999-2020. World J Clin Oncol. 2025;16(6):108393. doi: 10.5306\/wjco.v16.i6.108393.","journal-title":"World J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s12672-025-03880-7","type":"journal-article","article-title":"Single cell transcriptomic analysis reveals molecular mechanisms of chemoresistance and immune microenvironment remodeling in ovarian cancer","volume":"16","author":"Hu","year":"2025","unstructured":"Hu X, Du C, Du D, Zhang Y, Gao H, Tao M. Single cell transcriptomic analysis reveals molecular mechanisms of chemoresistance and immune microenvironment remodeling in ovarian cancer. Discov Oncol. 2025;16:2118. doi: 10.1007\/s12672-025-03880-7.","journal-title":"Discov Oncol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/bioengineering9040166","type":"journal-article","article-title":"In vitro cancer models: a closer look at limitations on translation","volume":"9","author":"Antunes","year":"2022","unstructured":"Antunes N, Kundu B, Kundu SC, Reis RL, Correlo VM. In vitro cancer models: a closer look at limitations on translation. Bioengineering (Basel). 2022;9(4):166. doi: 10.3390\/bioengineering9040166.","journal-title":"Bioengineering (Basel)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fbioe.2016.00012","type":"journal-article","article-title":"In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform","volume":"4","author":"Katt","year":"2016","unstructured":"Katt ME, Placone AL, Wong AD, Xu ZS, Searson PC. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol. 2016;4:12. doi: 10.3389\/fbioe.2016.00012.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/biom13010103","type":"journal-article","article-title":"In vitro models of ovarian cancer: bridging the gap between pathophysiology and mechanistic models","volume":"13","author":"Lopez","year":"2023","unstructured":"Lopez E, Kamboj S, Chen C, Wang Z, Kellouche S, Leroy-Dudal J, et al. In vitro models of ovarian cancer: bridging the gap between pathophysiology and mechanistic models. Biomolecules. 2023;13(1):103. doi: 10.3390\/biom13010103.","journal-title":"Biomolecules"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.3390\/ijms21134806","type":"journal-article","article-title":"Modelling epithelial ovarian cancer in mice: classical and emerging approaches","volume":"21","author":"Zakarya","year":"2020","unstructured":"Zakarya R, Howell VM, Colvin EK. Modelling epithelial ovarian cancer in mice: classical and emerging approaches. Int J Mol Sci. 2020;21(13):4806. doi: 10.3390\/ijms21134806.","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fonc.2014.00026","type":"journal-article","article-title":"Recent technological advances in using mouse models to study ovarian cancer","volume":"4","author":"House","year":"2014","unstructured":"House CD, Hernandez L, Annunziata CM. Recent technological advances in using mouse models to study ovarian cancer. Front Oncol. 2014;4:26. doi: 10.3389\/fonc.2014.00026.","journal-title":"Front Oncol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"113150","DOI":"10.1016\/j.yexcr.2022.113150","type":"journal-article","article-title":"Experimental models for ovarian cancer research","volume":"416","author":"Tsang","year":"2022","unstructured":"Tsang SI, Hassan AA, To SKY, Wong AST. Experimental models for ovarian cancer research. Exp Cell Res. 2022;416(1):113150. doi: 10.1016\/j.yexcr.2022.113150.","journal-title":"Exp Cell Res"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.24272\/j.issn.2095-8137.2020.382","type":"journal-article","article-title":"Mouse models of epithelial ovarian cancer for preclinical studies","volume":"42","author":"Karakashev","year":"2021","unstructured":"Karakashev S, Zhang RG. Mouse models of epithelial ovarian cancer for preclinical studies. Zool Res. 2021;42(2):153-160. doi: 10.24272\/j.issn.2095-8137.2020.382.","journal-title":"Zool Res"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ygyno.2016.05.028","type":"journal-article","article-title":"Characterization of ovarian cancer cell lines as in vivo models for preclinical studies","volume":"142","author":"Hernandez","year":"2016","unstructured":"Hernandez L, Kim MK, Lyle LT, Bunch KP, House CD, Ning F, et al. Characterization of ovarian cancer cell lines as in vivo models for preclinical studies. Gynecol Oncol. 2016;142(2):332-340. doi: 10.1016\/j.ygyno.2016.05.028.","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41698-025-01153-8","type":"journal-article","article-title":"ZNF217 promotes ovarian cancer progression by impacting multiple pivotal steps in the metastatic process","volume":"9","author":"Wardrup","year":"2025","unstructured":"Wardrup KC, Hoffman J, Pandya MJ, Navarathna N, Tulapurkar ME, Padmanabhan A. ZNF217 promotes ovarian cancer progression by impacting multiple pivotal steps in the metastatic process. NPJ Precis Oncol. 2025;9:392. doi: 10.1038\/s41698-025-01153-8.","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/17460441.2018.1426567","type":"journal-article","article-title":"The latest animal models of ovarian cancer for novel drug discovery","volume":"13","author":"Magnotti","year":"2018","unstructured":"Magnotti E, Marasco WA. The latest animal models of ovarian cancer for novel drug discovery. Expert Opin Drug Discov. 2018;13(3):249-257. doi: 10.1080\/17460441.2018.1426567.","journal-title":"Expert Opin Drug Discov"},{"issue":"Suppl 1","key":"ref16","first-page":"29","type":"journal-article","article-title":"Emerging and evolving ovarian cancer animal models","volume":"8","author":"Bobbs","year":"2015","unstructured":"Bobbs AS, Cole JM, Cowden Dahl KD. Emerging and evolving ovarian cancer animal models. Cancer Growth Metastasis. 2015;8 Suppl 1:29-36. doi: 10.4137\/CGM.S21221.","journal-title":"Cancer Growth Metastasis"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","type":"journal-article","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","unstructured":"Ford CE, Werner B, Hacker NF, Warton K. The untapped potential of ascites in ovarian cancer research and treatment. Br J Cancer. 2020;123(1):9-16. doi: 10.1038\/s41416-020-0875-x.","journal-title":"Br J Cancer"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/cancers15020407","type":"journal-article","article-title":"Diagnostic and therapeutic pathway of advanced ovarian cancer with peritoneal metastases","volume":"15","author":"Ghirardi","year":"2023","unstructured":"Ghirardi V, Fagotti A, Ansaloni L, Valle M, Roviello F, Sorrentino L, et al. Diagnostic and therapeutic pathway of advanced ovarian cancer with peritoneal metastases. Cancers (Basel). 2023;15(2):407. doi: 10.3390\/cancers15020407.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"e0163521","DOI":"10.1371\/journal.pone.0163521","type":"journal-article","article-title":"NSG mice provide a better spontaneous model of breast cancer metastasis than athymic nude mice","volume":"11","author":"Puchalapalli","year":"2016","unstructured":"Puchalapalli M, Zeng X, Mu L, Anderson A, Hix Glickman L, Zhang M, et al. NSG mice provide a better spontaneous model of breast cancer metastasis than athymic nude mice. PLoS One. 2016;11(9):e0163521. doi: 10.1371\/journal.pone.0163521.","journal-title":"PLoS One"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/71138\/clinically-relevant-transplantable-tumor-models-for-studying","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:45:47Z","timestamp":1792586747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/71138\/clinically-relevant-transplantable-tumor-models-for-studying"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":19,"journal-issue":{"issue":"231","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/71138","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}